Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
Subscribe To Our Newsletter & Stay Updated
